Zoetis (ZTS) |
United States |
$79.845B |
43.66 |
Takeda Pharmaceutical (TAK) |
Japan |
$53.521B |
9.80 |
Astellas Pharma (ALPMY) |
Japan |
$28.103B |
17.35 |
Eisai (ESALY) |
Japan |
$20.036B |
22.22 |
Catalent (CTLT) |
United States |
$18.492B |
48.93 |
Grifols, S.A (GRFS) |
Spain |
$12.651B |
14.72 |
Jazz Pharmaceuticals (JAZZ) |
Ireland |
$9.415B |
15.73 |
United Therapeutics (UTHR) |
United States |
$9.080B |
17.63 |
Neurocrine Biosciences (NBIX) |
United States |
$8.967B |
20.66 |
IPSEN SA ADR (IPSEY) |
France |
$8.063B |
0.00 |
Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$7.997B |
0.00 |
Arrowhead Pharmaceuticals (ARWR) |
United States |
$6.954B |
0.00 |
Evotec AG (EVTCY) |
Germany |
$6.594B |
445.28 |
Orion OYJ (ORINY) |
Finland |
$5.789B |
20.11 |
Ionis Pharmaceuticals (IONS) |
United States |
$5.626B |
0.00 |
Sage Therapeutics (SAGE) |
United States |
$4.382B |
0.00 |
Hypermarcas (HYPMY) |
Brazil |
$3.997B |
15.77 |
Turning Point Therapeutics (TPTX) |
United States |
$3.571B |
0.00 |
Nektar Therapeutics (NKTR) |
United States |
$3.427B |
0.00 |
PTC Therapeutics (PTCT) |
United States |
$3.343B |
0.00 |
ChemoCentryx (CCXI) |
United States |
$3.124B |
0.00 |
Tilray (TLRY) |
Canada |
$2.995B |
0.00 |
Cronos Group (CRON) |
Canada |
$2.954B |
0.00 |
Relay Therapeutics (RLAY) |
United States |
$2.950B |
0.00 |
Taro Pharmaceutical Industries (TARO) |
Israel |
$2.904B |
17.99 |
Revolution Medicines (RVMD) |
United States |
$2.888B |
0.00 |
Pacira BioSciences (PCRX) |
United States |
$2.786B |
47.04 |
Corcept Therapeutics (CORT) |
United States |
$2.686B |
26.94 |
Organogenesis Holdings (ORGO) |
United States |
$2.685B |
161.38 |
Xencor (XNCR) |
United States |
$2.430B |
0.00 |
USANA Health Sciences (USNA) |
United States |
$2.076B |
17.18 |
BioCryst Pharmaceuticals (BCRX) |
United States |
$2.045B |
0.00 |
FibroGen (FGEN) |
United States |
$1.749B |
0.00 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$1.708B |
13.43 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$1.703B |
10.92 |
Heron Therapeutics (HRTX) |
United States |
$1.567B |
0.00 |
Sundial Growers (SNDL) |
Canada |
$1.561B |
0.00 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.524B |
0.00 |
AlloVir (ALVR) |
United States |
$1.468B |
0.00 |
Indivior (INVVY) |
United States |
$1.460B |
0.00 |
Translate Bio (TBIO) |
United States |
$1.446B |
0.00 |
ImmunoGen (IMGN) |
United States |
$1.444B |
0.00 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$1.426B |
0.00 |
Endo (ENDP) |
Ireland |
$1.358B |
2.05 |
Aclaris Therapeutics (ACRS) |
United States |
$1.348B |
0.00 |
Ocular Therapeutix (OCUL) |
United States |
$1.159B |
0.00 |
Zogenix (ZGNX) |
United States |
$1.056B |
0.00 |
Enanta Pharmaceuticals (ENTA) |
United States |
$1.006B |
0.00 |
Trillium Therapeutics (TRIL) |
Canada |
$0.992B |
0.00 |
CLINIGEN GP (CLIGF) |
United Kingdom |
$0.942B |
0.00 |
Radius Health (RDUS) |
United States |
$0.886B |
0.00 |
4D Molecular Therapeutics (FDMT) |
|
$0.881B |
0.00 |
Ardelyx (ARDX) |
United States |
$0.869B |
0.00 |
Vectura Group (VEGPF) |
United Kingdom |
$0.864B |
0.00 |
Bioventus (BVS) |
United States |
$0.840B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$0.819B |
30.60 |
Aerie Pharmaceuticals (AERI) |
United States |
$0.816B |
0.00 |
Esperion Therapeutics (ESPR) |
United States |
$0.757B |
0.00 |
Karyopharm Therapeutics (KPTI) |
United States |
$0.693B |
0.00 |
Silence Therapeutics (SLN) |
United Kingdom |
$0.689B |
0.00 |
Calliditas Therapeutics AB (CALT) |
Sweden |
$0.672B |
0.00 |
Chinook Therapeutics (KDNY) |
United States |
$0.650B |
0.00 |
Rafael Holdings (RFL) |
United States |
$0.628B |
0.00 |
Harpoon Therapeutics (HARP) |
United States |
$0.621B |
0.00 |
VAXART, INC (VXRT) |
United States |
$0.602B |
0.00 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.591B |
0.00 |
Nanobiotix S.A (NBTX) |
France |
$0.576B |
0.00 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.562B |
0.00 |
Siga Technologies (SIGA) |
United States |
$0.551B |
9.21 |
Marinus Pharmaceuticals (MRNS) |
United States |
$0.514B |
0.00 |
Sigilon Therapeutics (SGTX) |
|
$0.506B |
0.00 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.495B |
0.00 |
Molecular Templates (MTEM) |
United States |
$0.465B |
0.00 |
TherapeuticsMD (TXMD) |
United States |
$0.456B |
0.00 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$0.447B |
10.51 |
Spectrum Pharmaceuticals (SPPI) |
United States |
$0.444B |
0.00 |
Altimmune (ALT) |
United States |
$0.438B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.437B |
0.00 |
Flexion Therapeutics (FLXN) |
United States |
$0.437B |
0.00 |
AVITA Medical (RCEL) |
United States |
$0.435B |
0.00 |
Summit Therapeutics (SMMT) |
United States |
$0.427B |
0.00 |
PROFOUND MEDICL (PROF) |
Canada |
$0.407B |
0.00 |
Foghorn Therapeutics (FHTX) |
United States |
$0.397B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.388B |
18.49 |
Jounce Therapeutics (JNCE) |
United States |
$0.386B |
0.00 |
DURECT (DRRX) |
United States |
$0.373B |
0.00 |
Acutus Medical (AFIB) |
United States |
$0.364B |
0.00 |
MEI Pharma (MEIP) |
United States |
$0.362B |
0.00 |
Innate Pharma SA (IPHYF) |
France |
$0.352B |
0.00 |
Redhill Biopharma (RDHL) |
Israel |
$0.315B |
0.00 |
Oncternal Therapeutics (ONCT) |
United States |
$0.304B |
0.00 |
Clever Leaves Holdings (CLVR) |
United States |
$0.278B |
0.00 |
VYNE Therapeutics (VYNE) |
United States |
$0.263B |
0.00 |
Alpine Immune Sciences (ALPN) |
United States |
$0.262B |
0.00 |
Taiwan Liposome (TLC) |
Taiwan |
$0.256B |
0.00 |
Infinity Pharmaceuticals (INFI) |
United States |
$0.253B |
0.00 |
KemPharm (KMPH) |
United States |
$0.247B |
0.00 |
Inotiv (NOTV) |
United States |
$0.238B |
0.00 |
CASI Pharmaceuticals (CASI) |
United States |
$0.238B |
0.00 |
Dipexium Pharmaceuticals (PLXP) |
United States |
$0.229B |
0.00 |
Xeris Pharmaceuticals (XERS) |
United States |
$0.223B |
0.00 |
4D Pharma (LBPS) |
United Kingdom |
$0.216B |
0.00 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.205B |
0.00 |
Lannett Co Inc (LCI) |
United States |
$0.204B |
6.85 |
Sierra Oncology (SRRA) |
Canada |
$0.200B |
0.00 |
Progenity (PROG) |
United States |
$0.192B |
0.00 |
OptiNose (OPTN) |
United States |
$0.185B |
0.00 |
IMV INC (IMV) |
Canada |
$0.181B |
0.00 |
CTI BioPharma (CTIC) |
United States |
$0.180B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.180B |
0.00 |
Matinas Biopharma Holdings (MTNB) |
United States |
$0.180B |
0.00 |
Oasmia Pharmaceutical AB (OASMY) |
Sweden |
$0.179B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.177B |
0.00 |
Novan (NOVN) |
United States |
$0.173B |
0.00 |
Adherex Technologies (FENC) |
United States |
$0.163B |
0.00 |
Heat Biologics (HTBX) |
United States |
$0.161B |
0.00 |
Calithera Biosciences (CALA) |
United States |
$0.158B |
0.00 |
Gain Therapeutics (GANX) |
United States |
$0.158B |
0.00 |
Qilian Holding Group (QLI) |
China |
$0.158B |
0.00 |
SCYNEXIS (SCYX) |
United States |
$0.154B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.151B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.148B |
0.00 |
Onconova Therapeutics (ONTX) |
United States |
$0.145B |
0.00 |
Vivos Therapeutics (VVOS) |
|
$0.145B |
0.00 |
Aquestive Therapeutics (AQST) |
United States |
$0.143B |
0.00 |
AcelRx Pharmaceuticals (ACRX) |
United States |
$0.143B |
0.00 |
Ayala Pharmaceuticals (AYLA) |
Israel |
$0.138B |
0.00 |
Concert Pharmaceuticals (CNCE) |
United States |
$0.136B |
0.00 |
MediWound (MDWD) |
Israel |
$0.134B |
0.00 |
Aziyo Biologics (AZYO) |
United States |
$0.133B |
0.00 |
GlycoMimetics (GLYC) |
United States |
$0.127B |
0.00 |
Lipocine (LPCN) |
United States |
$0.123B |
0.00 |
IsoRay (ISR) |
United States |
$0.117B |
0.00 |
Otonomy (OTIC) |
United States |
$0.113B |
0.00 |
Genocea Biosciences (GNCA) |
United States |
$0.112B |
0.00 |
La Jolla Pharmaceutical (LJPC) |
United States |
$0.112B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.108B |
29.19 |
PolarityTE (PTE) |
United States |
$0.107B |
0.00 |
Adamis Pharmaceuticals (ADMP) |
United States |
$0.106B |
0.00 |
Minerva Neurosciences (NERV) |
United States |
$0.103B |
40.17 |
Savara (SVRA) |
United States |
$0.101B |
0.00 |
AIM ImmunoTech (AIM) |
United States |
$0.098B |
0.00 |
Nutriband (NTRB) |
United States |
$0.095B |
0.00 |
ElectroCore (ECOR) |
United States |
$0.090B |
0.00 |
Regulus Therapeutics (RGLS) |
United States |
$0.089B |
0.00 |
Aptorum Group (APM) |
Hong Kong, SAR China |
$0.089B |
0.00 |
Assertio Holdings (ASRT) |
United States |
$0.083B |
0.00 |
Recro Pharma (REPH) |
United States |
$0.083B |
0.00 |
ProPhase Labs (PRPH) |
United States |
$0.080B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.080B |
0.00 |
Baudax Bio (BXRX) |
United States |
$0.074B |
0.00 |
Entasis Therapeutics Holdings (ETTX) |
United States |
$0.072B |
0.00 |
Trimel Pharmaceuticals (ASPCF) |
Canada |
$0.068B |
0.00 |
Addex Therapeutics (ADXN) |
Switzerland |
$0.068B |
0.00 |
India Globalization Capital (IGC) |
United States |
$0.067B |
0.00 |
Sigyn Therapeutics (SIGY) |
United States |
$0.065B |
0.00 |
RENEURON GP (RNUGF) |
United Kingdom |
$0.062B |
0.00 |
Biomerica (BMRA) |
United States |
$0.058B |
0.00 |
Brickell Biotech (BBI) |
United States |
$0.056B |
0.00 |
AgeX Therapeutics (AGE) |
United States |
$0.053B |
0.00 |
Inhibikase Therapeutics (IKT) |
United States |
$0.052B |
0.00 |
Salarius Pharmaceuticals (SLRX) |
United States |
$0.052B |
0.00 |
HANCOCK JAFFE (HJLI) |
United States |
$0.051B |
0.00 |
Opiant Pharmaceuticals (OPNT) |
United States |
$0.046B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.045B |
59.80 |
Mannatech (MTEX) |
United States |
$0.041B |
7.32 |
Viracta Therapeutics (VIRX) |
United States |
$0.039B |
0.00 |
Can-Fite Biopharma (CANF) |
Israel |
$0.036B |
0.00 |
NovaBay Pharmaceuticals (NBY) |
United States |
$0.032B |
0.00 |
Eyegate Pharmaceuticals (EYEG) |
United States |
$0.031B |
0.00 |
RXi Pharmaceuticals (PHIO) |
United States |
$0.030B |
0.00 |
Petros Pharmaceuticals (PTPI) |
United States |
$0.029B |
0.00 |
Bellicum Pharmaceuticals (BLCM) |
United States |
$0.026B |
0.00 |
Midatech Pharma (MTP) |
United Kingdom |
$0.023B |
0.00 |
JanOne (JAN) |
United States |
$0.021B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.020B |
0.00 |
Plus Therapeutics (PSTV) |
United States |
$0.019B |
0.00 |
Cyanotech (CYAN) |
United States |
$0.019B |
15.45 |
SHINECO INC (TYHT) |
China |
$0.018B |
0.00 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.017B |
0.00 |
Xenetic Biosciences (XBIO) |
United States |
$0.016B |
0.00 |
CannTrust Holdings (CTST) |
Canada |
$0.000B |
0.00 |